A prospective study of fibroblast growth factor-23 in children with chronic kidney disease

Scandinavian Journal of Clinical and Laboratory Investigation

Volumn 70, Issue 1, 2010, Pages 15-20

  Magnusson, Per ^a,b   Hansson, Sverker ^c   Swolin Eide, Diana ^c  

^a LINKÖPING UNIVERSITY   (Sweden)

^b LINKÖPING UNIVERSITY HOSPITAL   (Sweden)

^c QUEEN SILVIA CHILDREN'S HOSPITAL   (Sweden)

Author keywords

Bone turnover; DXA; Osteocalcin; Osteoprotegerin; Pediatric; Phosphate; Renal osteodystrophy

Indexed keywords

FIBROBLAST GROWTH FACTOR 23; MOLECULAR MARKER; OSTEOCALCIN; PARATHYROID HORMONE;

ADOLESCENT; ARTICLE; BONE DENSITY; BONE MASS; BONE METABOLISM; BONE TURNOVER; CHILD; CHILDHOOD DISEASE; CHRONIC KIDNEY DISEASE; CLINICAL ARTICLE; FEMALE; FOLLOW UP; GLOMERULUS FILTRATION RATE; HUMAN; KIDNEY FAILURE; KIDNEY TRANSPLANTATION; LUMBAR SPINE; MALE; MINERAL METABOLISM; PRESCHOOL CHILD; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTEIN BLOOD LEVEL; SCHOOL CHILD;

ADOLESCENT; BIOLOGICAL MARKERS; BONE AND BONES; BONE DENSITY; CHILD; CHILD, PRESCHOOL; FEMALE; FIBROBLAST GROWTH FACTORS; GLOMERULAR FILTRATION RATE; HUMANS; KIDNEY FAILURE, CHRONIC; MALE; PROSPECTIVE STUDIES; RENAL INSUFFICIENCY, CHRONIC;

EID: 76749122815     PISSN: 00365513     EISSN: 15027686     Source Type: Journal    
DOI: 10.3109/00365510903359245     Document Type: Article

References (25)

1. Ben-Dov IZ, Galitzer H, Lavi-Moshayoff V, Goetz R, Kuro-o M, Mohammadi M, Sirkis R, Naveh-Many T, Silver J. The parathyroid is a target organ for FGF23 in rats. J Clin Invest 2007;117:4003-4008
2. Fukumoto S, Yamashita T. FGF23 is a hormone-regulating phosphate metabolism - unique biological characteristics of FGF23. Bone 2007;40:1190-1195
3. Masuyama R, Stockmans I, Torrekens S, Van Looveren R, Maes C, Carmeliet P, Bouillon R, Carmeliet G. Vitamin D receptor in chondrocytes promotes osteoclastogenesis and regulates FGF23 production in osteoblasts. J Clin Invest 2006;116:3150-3159
4. Riminucci M, Collins MT, Fedarko NS, Cherman N, Corsi A, White KE, Waguespack S, Gupta A, Hannon T, Econs MJ, Bianco P, Gehron Robey P. FGF-23 in fibrous dysplasia of bone and its relationship to renal phosphate wasting. J Clin Invest 2003;112:683-692
5. The ADHR Consortium. Autosomal dominant hypophosphataemic rickets is associated with mutations in FGF23. Nat Genet 2000;26:345-348
6. Imanishi Y, Inaba M, Nakatsuka K, Nagasue K, Okuno S, Yoshihara A, Miura M, Miyauchi A, Kobayashi K, Miki T, Shoji T, Ishimura E, Nishizawa Y. FGF-23 in patients with end-stage renal disease on hemodialysis. Kidney Int 2004;65:1943-1946
7. Larsson T, Nisbeth U, Ljunggren O, Juppner H, Jonsson KB. Circulating concentration of FGF-23 increases as renal function declines in patients with chronic kidney disease, but does not change in response to variation in phosphate intake in healthy volunteers. Kidney Int 2003;64:2272-2279
8. Silver J, Naveh-Many T. Phosphate and the parathyroid. Kidney Int 2009;75:898-905.
9. Kuizon BD, Salusky IB. Growth retardation in children with chronic renal failure. J Bone Miner Res 1999;14: 1680-1690
10. Kuizon BD, Salusky IB. Renal osteodystrophy: pathogenesis, diagnosis, and treatment. In: Glorieux FH, Pettifor JM, Juppner H, editors. Pediatric bone. Biology and diseases. London, UK: Academic Press; 2003. p. 679-701.
11. Salusky IB, Ramirez JA, Oppenheim W, Gales B, Segre GV, Goodman WG. Biochemical markers of renal osteodystrophy in pediatric patients undergoing CAPD/CCPD. Kidney Int 1994;45:253-258
12. Ziolkowska H, Panczyk-Tomaszewska M, Debinski A, Polowiec Z, Sawicki A, Sieniawska M. Bone biopsy results and serum bone turnover parameters in uremic children. Acta Paediatr 2000;89:666-671
13. Jonsson KB, Zahradnik R, Larsson T, White KE, Sugimoto T, Imanishi Y, Yamamoto T, Hampson G, Koshiyama H, Ljunggren O, Oba K, Yang IM, Miyauchi A, Econs MJ, Lavigne J, Juppner H. Fibroblast growth factor 23 in oncogenic osteomalacia and X-linked hypophosphatemia. N Engl J Med 2003;348:1656-1663 (Pubitemid 36459471)
14. Larsson T, Marsell R, Schipani E, Ohlsson C, Ljunggren O, Tenenhouse HS, Juppner H, Jonsson KB. Transgenic mice expressing fibroblast growth factor 23 under the control of the ?1(I) collagen promoter exhibit growth retardation, osteomalacia, and disturbed phosphate homeostasis. Endocrinology 2004;145:3087-3094
15. Sitara D, Razzaque MS, Hesse M, Yoganathan S, Taguchi T, Erben RG, Juppner H, Lanske B. Homozygous ablation of fibroblast growth factor-23 results in hyperphosphatemia and impaired skeletogenesis, and reverses hypophosphatemia in Phex-deficient mice. Matrix Biol 2004;23:421-432
16. Urena Torres P, Friedlander G, de Vernejoul MC, Silve C, Prie D. Bone mass does not correlate with the serum fibroblast growth factor 23 in hemodialysis patients. Kidney Int 2008;73:102-107
17. Schwartz GJ, Haycock GB, Edelmann Jr CM, Spitzer A. A simple estimate of glomerular filtration rate in children derived from body length and plasma creatinine. Pediatrics 1976;58:259-269
18. Swolin-Eide D, Hansson S, Larsson L, Magnusson P. The novel bone alkaline phosphatase B1x isoform in children with kidney disease. Pediatr Nephrol 2006;21:1723-1729
19. Westerberg P-A, Linde T, Wikstrom B, Ljunggren O, Stridsberg M, Larsson TE. Regulation of fibroblast growth factor-23 in chronic kidney disease. Nephrol Dial Transplant 2007;22:3202-3207
20. Wesseling-Perry K, Pereira RC, Wang H, Elashoff RM, Sahney S, Gales B, Juppner H, Salusky IB. Relationship between plasma fibroblast growth factor-23 concentration and bone mineralization in children with renal failure on peritoneal dialysis. J Clin Endocrinol Metab 2009;94: 511-517
21. Feber J, Cochat P, Braillon P. Bone mineral density in children after renal transplantation. Pediatr Nephrol 2000;14:654-657 (Pubitemid 30394447)
22. Shigematsu T, Kazama JJ, Yamashita T, Fukumoto S, Hosoya T, Gejyo F, Fukagawa M. Possible involvement of circulating fibroblast growth factor 23 in the development of secondary hyperparathyroidism associated with renal insuffi ciency. Am J Kidney Dis 2004;44:250-256
23. Nakanishi S, Kazama JJ, Nii-Kono T, Omori K, Yamashita T, Fukumoto S, Gejyo F, Shigematsu T, Fukagawa M. Serum fibroblast growth factor-23 levels predict the future refractory hyperparathyroidism in dialysis patients. Kidney Int 2005;67:1171-1178 (Pubitemid 41623344)
24. Cioffi M, Corradino M, Gazzerro P, Vietri MT, Di Macchia C, Contursi A, Colicigno R, Catalano T, Molinari AM. Serum concentrations of intact parathyroid hormone in healthy children. Clin Chem 2000;46:863-864
25. Burnett S-AM, Gunawardene SC, Bringhurst FR, Juppner H, Lee H, Finkelstein JS. Regulation of C-terminal and intact FGF-23 by dietary phosphate in men and women. J Bone Miner Res 2006;21:1187-1196